We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-5.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$496M
AUM Growth
-$67M
Cap. Flow
-$12.4M
Cap. Flow %
-2.49%
Top 10 Hldgs %
25.38%
Holding
128
New
22
Increased
39
Reduced
44
Closed
16

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$7.57M
2
IRTC icon
iRhythm Holdings
IRTC
+$6.12M
3
TVTX icon
Travere Therapeutics
TVTX
+$5.83M
4
LNTH icon
Lantheus
LNTH
+$5.59M
5
ALKS icon
Alkermes
ALKS
+$5.45M

Top Sells

Rank Stock Value
1
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$12.4M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$8.48M
3
HCAT icon
Health Catalyst
HCAT
+$6.58M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.99M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.45M

Sector Composition

Rank Sector Weight
1 Healthcare 95.62%
2 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
51
DELISTED
Blueprint Medicines
BPMC
$4.14M 0.83%
81,900
– –
ARWR icon
52
Arrowhead Research
ARWR
$12.3B
$4.11M 0.83%
116,800
-2,900
-2% -$109K
CNC icon
53
Centene
CNC
$30.1B
$4.07M 0.82%
48,050
+9,050
+23% +$752K
HZNP
54
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.97M 0.8%
49,825
+350
+0.7% +$33.1K
AMGN icon
55
Amgen
AMGN
$209B
$3.96M 0.8%
16,290
+5,140
+46% +$1.26M
ARQT icon
56
Arcutis Biotherapeutics
ARQT
$3.5B
$3.84M 0.77%
180,016
-39,120
-18% -$802K
RCKT icon
57
Rocket Pharmaceuticals
RCKT
$351M
$3.73M 0.75%
270,790
-33,185
-11% -$396K
CERT icon
58
Certara
CERT
$1.21B
$3.71M 0.75%
173,129
-82,455
-32% -$1.63M
NTLA icon
59
Intellia Therapeutics
NTLA
$1.55B
$3.69M 0.74%
71,380
-820
-1% -$41.6K
IQV icon
60
IQVIA
IQV
$39.1B
$3.47M 0.7%
+16,000
New +$3.47M
EFTR
61
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$3.38M 0.68%
95,306
-4
-0% -$242
CYTK icon
62
Cytokinetics
CYTK
$10.9B
$3.3M 0.66%
84,000
+14,000
+20% +$564K
TMO icon
63
Thermo Fisher Scientific
TMO
$214B
$3.17M 0.64%
5,840
-10,885
-65% -$5.99M
JBIO
64
Jade Biosciences
JBIO
$1.22B
$3.06M 0.62%
5,601
-654
-10% -$312K
ITOS
65
DELISTED
iTeos Therapeutics
ITOS
$3.05M 0.61%
147,900
-86,250
-37% -$2.05M
KRTX
66
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.04M 0.61%
+24,020
New +$2.76M
MOH icon
67
Molina Healthcare
MOH
$10.2B
$2.87M 0.58%
10,275
+2,125
+26% +$642K
BMY icon
68
Bristol-Myers Squibb
BMY
$132B
$2.81M 0.57%
36,500
+8,500
+30% +$647K
BIIB icon
69
Biogen
BIIB
$30.7B
$2.75M 0.55%
13,502
-3,700
-22% -$756K
MASS icon
70
908 Devices
MASS
$313M
$2.71M 0.55%
131,757
-3,115
-2% -$52.3K
ELV icon
71
Elevance Health
ELV
$81.6B
$2.65M 0.53%
5,500
-1,400
-20% -$693K
RLYB icon
72
Rallybio
RLYB
$85.3M
$2.61M 0.53%
43,165
-4,969
-10% -$373K
MRNA icon
73
Moderna
MRNA
$23B
$2.58M 0.52%
18,093
+888
+5% +$127K
MRVI icon
74
Maravai LifeSciences
MRVI
$996M
$2.54M 0.51%
89,250
+4,250
+5% +$135K
NVAX icon
75
Novavax
NVAX
$1.22B
$2.53M 0.51%
49,200
-1,300
-3% -$67.3K
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sectoral Asset Management held 128 positions worth $496M, down 12% from $563M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sectoral Asset Management's Q2 2022 filing shows 22 new, 39 increased, 44 reduced and 16 closed positions. Its largest new stake was Travere Therapeutics: 232,000 shares worth $5.62M. The largest sale was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q2 2022 buy was Travere Therapeutics: 232,000 shares worth $5.62M.
  • Sectoral Asset Management added most to Icon in Q2 2022, an estimated $7.57M increase.
  • Sectoral Asset Management's biggest Q2 2022 reduction was Turning Point Therapeutics, Inc. Common Stock, cutting an estimated $8.48M.
  • Sectoral Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $12.4M.
  • Sectoral Asset Management's ten largest holdings make up 25% of its $496M portfolio in Q2 2022.
  • Sectoral Asset Management opened 22 new positions and closed 16 in Q2 2022.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $496M.

Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.